Tags Archive Navigation
icon
-
StoryCompassionate use: Providing access to much needed treatments
-
Media ReleaseNovartis pledges 10-year commitment with Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and other leading organizations to co-create effective, measurable solutions for health equity
-
Media ReleaseNovartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19
-
Media ReleaseNovartis Resolves Legacy FCPA Investigations
-
Media ReleaseNovartis resolves legacy litigation matters, finalizing settlement of speaker program litigation with Government in the US and positioning company for the future by fully scaling its next-generation digital engagement technologies
-
Media ReleaseNovartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
-
Media ReleaseNovartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
-
StoryIn your neighborhood: a community-based approach to health equity in the US
-
StoryDoing the right thing is good business
-
StoryPositive gains are needed to accelerate change for women with lung disease
-
StorySleuths use hi-tech sensors to fight pharmaceutical crime
-
StoryWomen in Science: Jean Silveri